Drug Delivery tech
Total Trials
16
As Lead Sponsor
15
As Collaborator
1
Total Enrollment
1,027
NCT02234115
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma
Phase: Phase 3
Role: Lead Sponsor
Start: Aug 31, 2014
Completion: Jan 5, 2017
NCT02238834
Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers
Phase: Phase 1
Start: Jun 30, 2015
Completion: Dec 31, 2018
NCT02712320
Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg
Start: Feb 29, 2016
Completion: Dec 19, 2017
NCT03304964
A Phase 1, Pharmacokinetics of the MMP-12 Inhibitor FP-025 After Multiple Oral Ascending Doses in Healthy Subjects
Start: Jul 21, 2017
Completion: Jul 1, 2018
NCT03261999
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer
Start: Sep 26, 2017
Completion: Feb 1, 2019
NCT03686930
Multiple-Dose, Dose-Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045
Start: Feb 22, 2018
Completion: Aug 10, 2018
NCT03858686
The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.
Phase: Phase 2
Start: Jul 2, 2018
Completion: Dec 30, 2022
NCT04750278
A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19
Phase: Phase 2/3
Start: Apr 6, 2021
Completion: Apr 18, 2022
NCT04761393
Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum
Phase: N/A
Role: Collaborator
Start: Nov 29, 2022
Completion: Jan 31, 2025
NCT05493709
Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
Start: Jun 2, 2023
Completion: Jun 30, 2026
NCT04522375
A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia
Phase: Phase 1/2
Start: Jun 30, 2023
Completion: Dec 31, 2025
NCT06334211
Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers
Start: Apr 16, 2024
Completion: Sep 20, 2024
NCT06475781
Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD
Start: Mar 1, 2025
Completion: Aug 31, 2028
NCT06795191
Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer
Start: Jun 1, 2025
Completion: Jan 2, 2028
NCT06795178
Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer
Start: Jul 1, 2025
Completion: Feb 2, 2028
NCT07191535
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)
Start: Jan 1, 2026
Completion: Sep 1, 2027
Loading map...